China drugs: A cautionary tale
Wall Street Journal (subscription required), January 31, 2008
A contaminated anticancer drug made by one of China's largest pharmaceutical companies underscores how quality-control problems continue to plague the Chinese drug industry. There is no sign the tainted leukemia drug was exported. But the case provides a cautionary tale as Western pharmaceutical companies start outsourcing some manufacturing to China.